← All quick references

ClearRounds Health · Cardiology · Quick Reference

Valvular Disease Overview

PDF coming soon
Valvular & Structural Heart DiseaseIntermediateIn progressOne-page PDF

AS, AR, MS, MR, TR overview; pathophysiology, murmur clues, echo monitoring intervals, intervention triggers, and referral.

Combines aortic, mitral, and tricuspid lesions on one overview sheet.

Last reviewed

Pending initial clinical review

Sources / guidelines to verify

  • 2020 ACC/AHA Valvular Heart Disease Guideline
Disclaimer: Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.

One-page reference

Draft content pending the site owner’s clinical review. Verify against the sources above and local protocol before clinical use.

1

What it is / why it matters

  • Aortic stenosis (AS), aortic regurgitation (AR), mitral stenosis (MS), mitral regurgitation (MR), tricuspid regurgitation (TR).
  • Severity + symptoms + ventricular response drive the timing of intervention. Echo is the workhorse.
2

Key diagnostic clues

Murmurs

  • AS: systolic crescendo–decrescendo radiating to carotids
  • MR: holosystolic radiating to axilla
  • AR: early diastolic, decrescendo
  • MS: opening snap + diastolic rumble

Symptoms

  • Dyspnea, angina, syncope, heart failure
3

Initial workup

  • TTE to grade severity and assess LV size/function.
  • Serial echo intervals by severity; TEE, cath, or CT as needed.
  • Careful symptom history — patients often self-limit activity.
4

Management framework

  • Refer to a valve / heart team for intervention decisions.
  • Severe symptomatic AS → aortic valve replacement (TAVR or SAVR by heart team).
  • Severe asymptomatic AS with LV dysfunction (EF <50%) or abnormal stress → consider AVR.
  • Severe primary MR, symptomatic or with LV changes (EF 30–60% / LVESD ≥40 mm) → repair preferred.
  • Medical therapy treats HF/AF/BP but does not fix mechanical lesions — don’t delay needed intervention.
5

Red flags / escalate now

  • New heart failure, syncope, or angina with severe valve disease.
  • Rapid symptom change → expedite referral.
6

Follow-up / monitoring

  • Serial echo per severity (e.g., severe asymptomatic AS every 6–12 months; moderate every 1–2 years).
  • Ongoing symptom surveillance and endocarditis awareness.
7

Clinic pearls

  • Symptom onset in severe AS is a turning point — untreated prognosis is poor, so refer.
  • "Asymptomatic" severe AS needs a careful history; TAVR vs SAVR is a heart-team decision.

Related quick references

Suggest an edit or request this reference

Spot something to improve, or want this one-pager prioritized? Send feedback to the ClearRounds Health team.

Share feedback →
ClearRounds Health · Cardiology — Valvular Disease Overview Quick Reference · Last reviewed: Pending initial clinical review · Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.